Saxendas approval set a precedent in efficacy and pricing, with a cost of over $1,000 per month
Our experienced R&D, production, sales, and customer service teams ensure reliable products and professional support
In Phase 2 trials, participants began on a low dose and were gradually escalated over several weeks to higher maintenance doses, up to 12 mg weekly
Intramuscular injection typically causes sharper pain during injection, more bleeding afterward, and sometimes a dull ache that persists for hours
DPP4 inhibitor induces beta cell regeneration and DDR-1 protein expression as an endocrine progenitor cell marker in neonatal STZ-diabetic rats
This Privacy Policy describes Our policies and procedures on the collection, use and disclosure of Your information when You use Our Website and tells You about Your privacy rights and how the law protects You